[go: up one dir, main page]

TW200502398A - Use of peptidylarginine deiminase type IV - Google Patents

Use of peptidylarginine deiminase type IV

Info

Publication number
TW200502398A
TW200502398A TW093101528A TW93101528A TW200502398A TW 200502398 A TW200502398 A TW 200502398A TW 093101528 A TW093101528 A TW 093101528A TW 93101528 A TW93101528 A TW 93101528A TW 200502398 A TW200502398 A TW 200502398A
Authority
TW
Taiwan
Prior art keywords
rheumatoid arthritis
peptidylarginine deiminase
type
gene
effects
Prior art date
Application number
TW093101528A
Other languages
Chinese (zh)
Inventor
Kazuhiko Yamamoto
Ryo Yamada
Akari Horiguchi
xiao-tian Chang
Hidehiko Furukawa
Mitsuru Ono
Reimi Mikami
Makiko Nakayama
Masahiko Ohtsuki
Masakatsu Suzuki
Miyuki Nagasaki
Original Assignee
Riken
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken, Sankyo Co filed Critical Riken
Publication of TW200502398A publication Critical patent/TW200502398A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03015—Protein-arginine deiminase (3.5.3.15)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

This invention relates to a method for evaluating the effects of a medicine for rheumatoid arthritis therapy, by using peptidylarginine deiminase type IV, and to a method for predicting the risk of incidence of a rheumatoid arthritis. In other words, this invention provids a method for evaluating the effects of a test substance as a medicine for rheumatoid arthritis therapy, which is using peptidylarginine deiminase gene type IV or its ortholog, or the inhibition effects against the protein encoded by the said gene as a marker. In addition, this invention provids a method for predicting the risk of incidence of a rheumatoid arthritis in a subject, which is based on the expression level of a mutant protein of peptidylarginine deiminase type IV having amino acids sequence of SEQ ID NO:21 or the gene(SEQ ID NO:20) in a specimen.
TW093101528A 2003-01-21 2004-01-20 Use of peptidylarginine deiminase type IV TW200502398A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003012738 2003-01-21
JP2003012774 2003-01-21

Publications (1)

Publication Number Publication Date
TW200502398A true TW200502398A (en) 2005-01-16

Family

ID=32775167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093101528A TW200502398A (en) 2003-01-21 2004-01-20 Use of peptidylarginine deiminase type IV

Country Status (3)

Country Link
JP (1) JP4503531B2 (en)
TW (1) TW200502398A (en)
WO (1) WO2004065633A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029619A1 (en) * 2006-09-07 2008-03-13 Daiichi Sankyo Company, Limited Ena antisense oligonucleotide having sequence-specific action
JP5252339B2 (en) * 2007-12-25 2013-07-31 地方独立行政法人東京都健康長寿医療センター Method for measuring PAD4 and anti-PAD4 antibody and method for detecting rheumatoid arthritis
AU2010233926B2 (en) * 2009-03-30 2014-01-16 Inserm (Institut National De La Sante Et De La Recherche Medicale) Biomarkers, methods and kits for the diagnosis of Rheumatoid Arthritis

Also Published As

Publication number Publication date
JP4503531B2 (en) 2010-07-14
JPWO2004065633A1 (en) 2006-05-18
WO2004065633A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
Yang et al. Rubiscolin, a δ selective opioid peptide derived from plant Rubisco
DK2014678T3 (en) KDR peptides and vaccines containing them
WO2008060813A3 (en) High affinity antibody antagonists of interleukin-13 receptor alpha 1
DK1005540T3 (en) IKK-beta proteins, nucleic acids and methods
SI2071028T1 (en) HLA-DR-binding antigen peptide derived from WT1
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
NZ599590A (en) Factor involved in latent infection with herpesvirus, and use thereof
Reynolds Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D, D-peptidases and D, D-carboxypeptidases
AU2126400A (en) Detection of small molecules by use of a piezoelectric sensor
TW200502398A (en) Use of peptidylarginine deiminase type IV
AU2001289034A1 (en) Novel pdes and uses thereof
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
PL374550A1 (en) Il-17 like molecules and uses thereof
WO1999066051A3 (en) Nek-related and bub1-related protein kinases
WO1999062315A3 (en) Method for altering the activity of proteins of the pka signaling pathway
CA2367468A1 (en) Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
WO2008153072A1 (en) Gene sensitive to bone/joint disease and use thereof
ATE387460T1 (en) METHOD AND KIT FOR ASSESSING THE OUTBREAK OF RHEUMATOID ARTHRITIS
EP1796707A4 (en) PEPTIDES SELECTIVELY TARGETING THE CARDIOVASCULAR SYSTEM AND CONJUGATES AND ASSOCIATED METHODS
Ishida et al. Development of a novel peptide inhibitor of subtilisin BPN′
WO2007001943A3 (en) Prefoldin 4 in the treatment and diagnosis of cancer
EP0856582A3 (en) Inhibitor protein of transcription factors and its DNA
DE602006004966D1 (en) INTRINSIC FACTOR FROM THE PIG
EP1086377B1 (en) A method of identifying ligands to rna polymerase sigma 70 subunit
BR9914090A (en) nucleic acids encoding a gamma subunit of the g protein involved in sensory transduction